Jaypirca, the first and only FDA-approved non-covalent (reversible) BTK inhibitor, is a highly selective kinase inhibitor that utilizes a novel non-covalent binding mechanism to extend the benefit of ...
QDs can bind covalently or non-covalently to biomolecules like antibodies, proteins, peptides, aptamer nucleic acids, small molecules, liposomes, lectins, and monosaccharides to identify specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results